NATERA INC's ticker is NTRA and the CUSIP is 632307104. A total of 323 filers reported holding NATERA INC in Q1 2023. The put-call ratio across all filers is 0.49 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $88,776 | -80.7% | 2,210 | -55.1% | 0.00% | -75.0% |
| Q4 2021 | $459,000 | -54.2% | 4,920 | -45.3% | 0.02% | -50.0% |
| Q3 2021 | $1,002,000 | -42.8% | 8,989 | -41.7% | 0.03% | -22.0% |
| Q2 2021 | $1,751,000 | -7.2% | 15,427 | -16.9% | 0.04% | -8.9% |
| Q1 2021 | $1,886,000 | -7.7% | 18,572 | -9.6% | 0.04% | +4.7% |
| Q4 2020 | $2,044,000 | +10.4% | 20,543 | -19.9% | 0.04% | +4.9% |
| Q3 2020 | $1,852,000 | +11.4% | 25,633 | -23.2% | 0.04% | +13.9% |
| Q2 2020 | $1,663,000 | +38.0% | 33,356 | -17.3% | 0.04% | +24.1% |
| Q1 2020 | $1,205,000 | -7.5% | 40,344 | +4.3% | 0.03% | 0.0% |
| Q4 2019 | $1,303,000 | +2.7% | 38,679 | 0.0% | 0.03% | 0.0% |
| Q3 2019 | $1,269,000 | -11.4% | 38,679 | -25.6% | 0.03% | -12.1% |
| Q2 2019 | $1,433,000 | +138.8% | 51,953 | +78.6% | 0.03% | +135.7% |
| Q1 2019 | $600,000 | +115.8% | 29,087 | +150.4% | 0.01% | +133.3% |
| Q3 2018 | $278,000 | -47.1% | 11,616 | -58.5% | 0.01% | -50.0% |
| Q2 2018 | $526,000 | – | 27,966 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 881,436 | $48,937,327 | 32.36% |
| Kynam Capital Management, LP | 2,918,237 | $162,020,518 | 20.92% |
| Sofinnova Investments, Inc. | 3,100,560 | $172,143,091 | 11.01% |
| Eversept Partners, LP | 2,819,770 | $156,553,630 | 10.92% |
| Eagle Health Investments LP | 784,894 | $43,577,315 | 8.48% |
| Lagoda Investment Management, L.P. | 162,625 | $9,028,940 | 6.42% |
| BEACONLIGHT CAPITAL, LLC | 204,567 | $11,357,560 | 6.00% |
| Bain Capital Life Sciences Investors, LLC | 700,197 | $38,875 | 4.86% |
| PERKINS CAPITAL MANAGEMENT INC | 62,700 | $3,481 | 3.28% |
| RTW INVESTMENTS, LP | 2,611,783 | $145,006,192 | 3.02% |